Simultaneously analyze 65 cytokine, chemokine, and growth factor targets for effective profiling of immune response, biomarker discovery, and validation. The panel is provided in a ready-to-use format...
Simultaneously analyze 65 cytokine, chemokine, and growth factor targets for effective profiling of immune response, biomarker discovery, and validation. The panel is supplied in a ready-to-use format with individual vials of capture and detection reagents formulated at a concentration of 1X, requiring less pipeting and experimental configuration.
ProcartaPlex preconfigured panels are widely tested for combinability, interference and cross-reactivity of analyses to provide the highest level of validation and accuracy. All ProcartaPlex panels are supplied with the reagents necessary to perform the dosage.
Target list [microbead region]:
Cytokines: G-CSF (CSF-3) [42], GM-CSF [44], IFN alpha [48], IFN gamma [43], IL-1 alpha [62], IL-1 beta [18], IL-2 [19], IL-3 [73], IL-4 [20], IL-5 [21], IL-6 [25], IL-7 [26], IL-8 (CXCL8) [27], IL-9 [52], IL-10 [28], IL-12p70 [34], IL-13 [35], IL-15 [65], IL-16 [70], IL-17A (CTLA-8) [36], IL-18 [66], IL-20 [81], IL-21 [72], IL-22 [76], IL-23 [63], IL-27 [14], IL-31 [37], LIF [15], M-CSF [67], MIF [53], TNF alpha [45], TNF beta [54], TSLP [80]
Chimiokins: BLC (CXCL13) [29], ENA-78 (CXCL5) [82], Eotaxin (CCL11) [33], Eotaxin-2 (CCL24) [37], Eotaxin-3 (CCL26) [77], Fractalkine (CX3CL1) [59], Gro-alpha (CXCL1) [61], IP-10 (CXCL10) [22], I-TAC (CXCL11) [57], MCP-1 (CCL2) [51], MCP-2 (CCL8) [8], MCP-3 (CCL7) [68], MDC (CCL22) [87], MIG (CXCL9) [69], MIP-1 alpha (CCL3) [12], MIP-1 beta (CCL4) [47], MIP-3 alpha (CCL20) [56], SDF-1 alpha (CXCL12) [13]
Growth factors / regulators: FGF-2 [75], HGF [46], MMP-1 [64], NGF beta [55], SCF [39], VEGF-A [78]
Soluble receptors: APRIL [88], BAFF [86], CD30 [84], CD40L (CD154) [74], IL-2R (CD25) [22], TNF-RII [85], TRAIL (CD253) [58], TWEAK [97]
About ProcartaPlex strengths for Luminex platform
ProcartaPlex immunoassays are based on the principles of a sandwich ELISA, using two highly specific antibodies binding to different epitopes of a protein to quantify all target proteins simultaneously using a Luminex instrument. ProcartaPlex multiplex assays require only 25 µl plasma or serum, or 50 µl cell culture supernatant, and only four hours to obtain the analyzed results.
• Reproducible and reliable results — validated in panel to the highest industry standard, with tests for protein target combinationability and cross-reactivity
• Plus of results per sampler — allows multiple protein targets to be achieved simultaneously in a single sample of 25 - 50 µl
• High-reference multiplexing platform with well established Luminex technology for protein detection and quantification
ProcartaPlex assays use Luminex xMAP (multianalyte profiling) Technology for simultaneous detection and quantification of up to 80 protein targets in a single 25–50 µl sample — plasma, serum, cell culture supernatant and other body fluids.